Arizona State Retirement System Has $36.52 Million Stock Position in CVS Health Corporation $CVS

Arizona State Retirement System increased its stake in CVS Health Corporation (NYSE:CVS) by 1.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 353,014 shares of the pharmacy operator’s stock after purchasing an additional 5,257 shares during the period. Arizona State Retirement System’s holdings in CVS Health were worth $36,519,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Kilter Group LLC bought a new position in CVS Health in the 2nd quarter valued at about $27,000. Beaird Harris Wealth Management LLC lifted its holdings in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the period. J.Safra Asset Management Corp acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $30,000. Timbuktu Capital Management LLC bought a new position in CVS Health in the second quarter valued at approximately $31,000. Finally, Dunhill Financial LLC acquired a new position in CVS Health during the second quarter valued at approximately $32,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.6%

CVS traded down $0.63 during trading on Tuesday, reaching $96.11. 4,195,902 shares of the company’s stock were exchanged, compared to its average volume of 8,264,494. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The firm has a fifty day moving average price of $100.65 and a two-hundred day moving average price of $90.35. The stock has a market capitalization of $122.93 billion, a PE ratio of 25.43, a price-to-earnings-growth ratio of 0.94 and a beta of 0.59.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s payout ratio is presently 70.37%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CVS. HSBC reissued a “hold” rating and set a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. increased their target price on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. TD Cowen raised their price target on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Finally, Truist Financial lifted their price target on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Twenty-two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $106.83.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.